Eric is proud to help companies maximize patient access to life-saving medications and is passionate about driving toward value-based healthcare in the U.S.

Eric has five years of consulting experience focused on market access, pricing and contracting strategy in the U.S. He has worked across a variety of therapy areas and has deep expertise in oncology/biosimilar markets. 

Eric’s expertise lies in the end-to-end design and execution of market access and pricing strategies. He has worked with over 25 products in highly competitive markets including MS, rheumatoid arthritis, hemophilia, oncology and respiratory. 

Prior to his role at ZS, Eric worked for a software consulting company in Boston leading a PMO for mobile banking

Eric holds a B.S in business administration from Boston University and is currently pursuing his MBA from the Haas School of Business at the University of California, Berkeley.